• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Does a diffuse growth pattern predict for survival in patients with low-grade follicular lymphoma?

作者信息

Bhagavathi Sharathkumar, Gu Keni, Loberiza Fausto R, Bast Martin, Vose Julie M, Weisenburger Dennis D

机构信息

Department of Pathology, Indiana University, Indianapolis, IN, USA.

出版信息

Leuk Lymphoma. 2009 Jun;50(6):900-3. doi: 10.1080/10428190902919192.

DOI:10.1080/10428190902919192
PMID:19504394
Abstract

Low-grade follicular lymphoma (LGFL) is known to have a good prognosis. However, the clinical relevance of the presence and extent of diffuse growth areas within LGFL is not clear. Therefore, we studied 457 patients with nodal LGFL seen over a 20-year period (1982-2002). Relevant clinical and survival data were obtained and the pathology specimens were subclassified into predominantly follicular LGFL (>or=80% follicular areas), significantly follicular LGFL (30-70% follicular areas), significantly diffuse LGFL (<30% follicular areas) and pure diffuse follicle centre lymphoma (DFCL). The majority of the patients were treated with anthracycline-based regimens. Patients with DFCL were slightly older (median age, 67 years), more likely to have bulky disease (>5 cm), and often had suboptimal biopsies. However, no association was observed between the extent of diffuse areas and survival across the four subgroups. We conclude that the subclassification of LGFL based on the extent of diffuse areas does not have clinical relevance.

摘要

相似文献

1
Does a diffuse growth pattern predict for survival in patients with low-grade follicular lymphoma?
Leuk Lymphoma. 2009 Jun;50(6):900-3. doi: 10.1080/10428190902919192.
2
Ovarian non-Hodgkin's lymphoma: a clinicopathologic study of eight primary cases.卵巢非霍奇金淋巴瘤:8例原发性病例的临床病理研究
Mod Pathol. 2001 Nov;14(11):1093-9. doi: 10.1038/modpathol.3880442.
3
Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.原发性皮肤滤泡性淋巴瘤:临床、组织病理学、免疫表型及分子特征评估
J Clin Oncol. 2002 Feb 1;20(3):647-55. doi: 10.1200/JCO.2002.20.3.647.
4
Cutaneous presentation of follicular lymphomas.滤泡性淋巴瘤的皮肤表现
Mod Pathol. 2001 Sep;14(9):913-9. doi: 10.1038/modpathol.3880411.
5
Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.在接受含利妥昔单抗治疗的滤泡性淋巴瘤中,组织学分级和 Bcl-2 表达强度的预后意义。
Hum Pathol. 2013 Nov;44(11):2529-35. doi: 10.1016/j.humpath.2013.06.013. Epub 2013 Jul 31.
6
[Clinicopathologic analysis of intestinal follicular lymphoma first presenting with gastrointestinal symptoms].以胃肠道症状为首发表现的肠道滤泡性淋巴瘤的临床病理分析
Zhonghua Bing Li Xue Za Zhi. 2012 May;41(5):320-5. doi: 10.3760/cma.j.issn.0529-5807.2012.05.008.
7
[Primary cutaneous follicle centre lymphoma: report of a case].[原发性皮肤滤泡中心淋巴瘤:一例报告]
Zhonghua Bing Li Xue Za Zhi. 2013 Nov;42(11):769-70.
8
High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.大剂量环磷酰胺联合重组人粒细胞集落刺激因子(rhG-CSF)治疗滤泡性、低级别非霍奇金淋巴瘤:癌症与白血病研究组B(CALGB)9150研究
Leuk Lymphoma. 2001 Nov-Dec;42(6):1255-64. doi: 10.3109/10428190109097750.
9
Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.接受强化化疗的滤泡性大细胞淋巴瘤:对LNH87试验纳入的89例病例的分析及与弥漫性大B细胞淋巴瘤结局的比较。成人淋巴瘤研究组
J Clin Oncol. 1997 Apr;15(4):1654-63. doi: 10.1200/JCO.1997.15.4.1654.
10
[A rare thyroid tumor].[一种罕见的甲状腺肿瘤]
Ann Pathol. 2010 Apr;30(2):148-50. doi: 10.1016/j.annpat.2009.12.004. Epub 2010 Mar 1.

引用本文的文献

1
CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma.CREBBP 和 STAT6 共突变以及 16p13 和 1p36 缺失定义了 t(14;18)-阴性弥漫性滤泡淋巴瘤的变体。
Blood Cancer J. 2020 Jun 17;10(6):69. doi: 10.1038/s41408-020-0335-0.
2
New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009.恶性淋巴瘤病理学的新进展:2009年1月至8月发表文献综述
J Hematop. 2009 Sep 26;2(3):171-83. doi: 10.1007/s12308-009-0046-8.